Annual report pursuant to Section 13 and 15(d)

Fair Value of Financial Instruments (Tables)

v3.22.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Feb. 28, 2022
Fair Value Disclosures [Abstract]  
Fair value measurement inputs The inputs used to estimate the fair value of the November 2018 Canopy Warrants are as follows (1) (2):
February 28, 2022 February 28, 2021
Tranche A Warrants (3)
Tranche B Warrants (4)
Tranche A Warrants (3)
Tranche B Warrants (4)
Exercise price (5)
C$ 50.40  C$ 76.68  C$ 50.40  C$ 76.68 
Valuation date stock price (6)
C$ 9.04  C$ 9.04  C$ 41.90  C$ 41.90 
Remaining contractual term (7)
1.7 years 4.7 years 2.7 years 5.7 years
Expected volatility (8)
75.0  % 75.0  % 70.0  % 70.0  %
Risk-free interest rate (9)
1.4  % 1.7  % 0.5  % 1.1  %
Expected dividend yield (10)
0.0  % 0.0  % 0.0  % 0.0  %
(1)The exercise price for the Tranche C Warrants is based on the VWAP Exercise Price. The Tranche C Warrants are not included in the table as there is no fair value assigned.
(2)In connection with the Acreage Transaction, we obtained other rights which include a share repurchase credit. If Canopy has not purchased the lesser of 27,378,866 Canopy common shares, or C$1,583.0 million worth of Canopy common shares for cancellation between April 18, 2019, and two-years after the full exercise of the Tranche A Warrants, we will be credited an amount that will reduce the aggregate exercise price otherwise payable upon each exercise of the Tranche B Warrants and Tranche C Warrants. The credit will be an amount equal to the difference between C$1,583.0 million and the actual price paid by Canopy in purchasing its common shares for cancellation. The likelihood of receiving the share repurchase credit if we were to fully exercise the Tranche A Warrants is remote, therefore, no fair value has been assigned.
(3)The fair value is estimated using the Black-Scholes option-pricing model (Level 2 fair value measurement).
(4)The fair value is estimated using Monte Carlo simulations (Level 2 fair value measurement).
(5)Based on the exercise price from the applicable underlying agreements.
(6)Based on the closing market price for Canopy common stock on the TSX as of the applicable date.
(7)Based on the expiration date of the warrants.
(8)Based on consideration of historical and/or implied volatility levels of the underlying equity security and limited consideration of historical peer group volatility levels.
(9)Based on the implied yield currently available on Canadian Treasury zero coupon issues with a remaining term equal to the expiration date of the applicable warrants.
(10)Based on historical dividend levels.
The inputs used to estimate the fair value of the Canopy Debt Securities are as follows:
February 28,
2022
February 28,
2021
Conversion price (1)
C$ 48.17  C$ 48.17 
Valuation date stock price (2)
C$ 9.04  C$ 41.90 
Remaining term (3)
1.4 years 2.4 years
Expected volatility (4)
75.0  % 57.6  %
Risk-free interest rate (5)
1.4  % 0.4  %
Expected dividend yield (6)
0.0  % 0.0  %
(1)Based on the rate which the Canopy Debt Securities may be converted into equity shares, or the equivalent amount of cash, at the option of the issuer.
(2)Based on the closing market price for Canopy common stock on the TSX as of the applicable date.
(3)Based on the contractual maturity date of the notes.
(4)Based on consideration of historical and/or implied volatility levels of the underlying equity security, adjusted for certain risks associated with debt securities, as appropriate.
(5)Based on the implied yield currently available on Canadian Treasury zero coupon issues with a term equal to the remaining contractual term of the Canopy Debt Securities.
(6)Based on historical dividend levels.
The inputs used to estimate the fair value of the November 2018 Canopy Warrants as of the June 27, 2019 modification date, were as follows:
Tranche A Warrants (1)
Tranche B Warrants (1)
Exercise price $ 50.40  $ 76.68 
Valuation date stock price $ 53.36  $ 53.36 
Remaining contractual term 4.3 years 7.3 years
Expected volatility 66.7  % 66.7  %
Risk-free interest rate 1.4  % 1.4  %
Expected dividend yield 0.0  % 0.0  %
(1)Refer to Note 7 for input descriptions.
Financial assets and liabilities measured at fair value on a recurring basis
The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis:
Fair Value Measurements Using
Quoted
Prices in
Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
(in millions)
February 28, 2022
Assets:
Foreign currency contracts $ —  $ 56.4  $ —  $ 56.4 
Commodity derivative contracts $ —  $ 91.0  $ —  $ 91.0 
November 2018 Canopy Warrants (1)
$ —  $ 36.3  $ —  $ 36.3 
Canopy Debt Securities (1)
$ —  $ 146.6  $ —  $ 146.6 
Liabilities:
Foreign currency contracts $ —  $ 17.8  $ —  $ 17.8 
Commodity derivative contracts $ —  $ 0.9  $ —  $ 0.9 
Swap lock contracts $ —  $ 0.4  $ —  $ 0.4 
February 28, 2021
Assets:
Foreign currency contracts $ —  $ 76.6  $ —  $ 76.6 
Commodity derivative contracts $ —  $ 21.2  $ —  $ 21.2 
November 2018 Canopy Warrants (1)
$ —  $ 1,639.7  $ —  $ 1,639.7 
Canopy Debt Securities (1)
$ —  $ 176.3  $ —  $ 176.3 
Liabilities:
Foreign currency contracts $ —  $ 9.7  $ —  $ 9.7 
Commodity derivative contracts $ —  $ 5.3  $ —  $ 5.3 
(1)
Unrealized net gain (loss) from the changes in fair value of our securities measured at fair value recognized in income (loss) from unconsolidated investments, are as follows:
February 28,
2022
February 28,
2021
(in millions)
November 2017 Canopy Warrants (i)
$ —  $ (61.8)
November 2018 Canopy Warrants (1,603.4) 823.3 
Canopy Debt Securities (41.3) 40.5 
$ (1,644.7) $ 802.0 
(i)
In May 2020, we exercised the November 2017 Canopy Warrants at an exercise price of C$12.98 per warrant share for C$245.0 million, or $173.9 million, and received 18.9 million common shares of Canopy.
Assets and liabilities measured at estimated fair value on a nonrecurring basis
The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented:
Fair Value Measurements Using
Quoted
Prices in
Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total Losses
(in millions)
For the Year Ended February 28, 2022
Long-lived assets $ —  $ —  $ 20.0  $ 665.9 
For the Year Ended February 28, 2021
Long-lived assets held for sale $ —  $ —  $ —  $ 24.0 
Trademarks —  —  4.0  6.0 
$ —  $ —  $ 4.0  $ 30.0 
For the Year Ended February 29, 2020
Long-lived assets held for sale $ —  $ —  $ 949.3  $ 449.7 
Trademarks (1)
—  —  —  11.0 
$ —  $ —  $ 949.3  $ 460.7 
(1)    The balance at February 29, 2020, has been reclassified to assets held for sale (see “Trademarks” below for further discussion).